The protease inhibitor, N-acetyl-L-leucyl-L-leucyl-L-norleucinal, decreases the pool of major histocompatibility complex class I-binding peptides and inhibits peptide trimming in the endoplasmic reticulum

Journal of Experimental Medicine

Volumn 183, Issue 4, 1996, Pages 1569-1578

  Hughes, Eric A ^a   Ortmann, Bodo ^a   Surman, Michael ^a   Cresswell, Peter ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLPHENYLALANINAL; DIMETHYL SULFOXIDE; HLA A2 ANTIGEN; HLA B27 ANTIGEN; HLA B7 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; N ACETYLLEUCYLLEUCYLMETHIONAL; PROTEINASE INHIBITOR; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CYTOSOL; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; IMMUNOPRECIPITATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN TRANSPORT;

AMINO ACID SEQUENCE; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL COMPARTMENTATION; CYSTEINE PROTEINASE INHIBITORS; CYTOSOL; ENDOPLASMIC RETICULUM; HISTOCOMPATIBILITY ANTIGENS CLASS I; LEUPEPTINS; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PEPTIDES; PROTEIN BINDING;

EID: 0029965803     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.4.1569     Document Type: Article

References (38)

1. Howard, J.C. 1995. Supply and transport of peptides presented by class I MHC molecules. Curr. Opin. Immunol. 7: 69-76.
2. 2-microglobulin complexes associate with TAP transporters before peptide binding. Nature (Lond.). 368:864-867.
3. Suh, W.K., M.F. Cohen-Doyle, K. Fruh, K. Wang, P.A Peterson, and D.B. Williams. 1994. Interaction of MHC class I molecules with the transporter associated with antigen processing. Science (Wash. DC) 26:1322 1326.
4. 2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2). Proc. Natl. Acad. Sci. USA. 91:12716-12720.
5. Henderson, R.A., H. Michel, K. Sakaguchi, J. Shabanowitz, E. Appella, D.F. Hunt, and V.H. Engelhard. 1992. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science (Wash. DC). 268: 262-264.
6. Wei, M.L., and P. Cresswell. 1992. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature (Lond.). 356:443-446.
7. Huczko, E.L., W.M. Bodnar, D. Benjamin, K. Sakaguchi, N.Z. Zhu, J. Shabanowitz, P.A Henderson, E Appella, D.F. Hunt, and V.A. Engelhard. 1993. Characteristics of endogenous peptides eluted from class I MHC molecule HLA-B7 determined by mass spectometry and computer modeling. J. Immunol. 151:2572-2587.
8. Aldrich, C.J., A. DeCloux, A.S. Woods, R.J. Cotler, M.J. Soloski, and J. Forman. 1994. Identification of a TAP-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell. 79:649-658.
9. Peters, J. 1994. Proteasomes: protein degradation machines of the cell. TIBS (Trends Biochem. Sci.). 19:377-382.
10. Ciechanover, A., and A. Schwartz. 1994. The ubiquitinmediated proteolytic pathway: mechanisms of recognition of the proteolytic substrate and involvement in the degradation of native cellular proteins. FASEB (Fed. Am. Soc. Exp. Biol.) J 8:182-191.
11. Ciechanover, A. 1994. The ubiquitin-proteasome proteolytic pathway. Cell. 79:13-21.
12. Murakami, Y., S. Matsufuji, T. Kameji, S. Hayashi, K. Igarashi, T. Tamura, K. Tanaka, and A. Ichihara. 1992. Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature (Lond.). 360:597-599.
13. Monaco, J.J. 1992. A molecular model of MHC class-I-restricted antigen processing Immunol. Today. 13:173-179.
14. Van Kaer, L., P. Ashton-Rickardt, M. Eichelberger, M. Gaczynska, K. Nagashima, K. Rock, A. Goldberg, P. Doherty, and S. Tonegawa. 1994. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity. 1:533-541.
15. Fehling, H.J., W. Swat, C. Laplace, R. Kuhn, K. Rajewsky, U. Muller, and H. Von Boehmer. 1994. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science (Wash. DC). 265:1234-1237.
16. Rock, K.L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A.L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 78:761-771.
17. Michalek, M., E. Grant, C. Gramm, A. Goldberg, and K. Rock. 1993. A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature (Lond.). 363:552-554.
18. 1 ubiquitin-activating enzyme in temperature-sensitive cell lines. J. Immunol. 154:511-519.
19. Lowe, J., D. Stock, B. Jap, P. Zwickl, W. Baumeister, and R. Huber. 1995. Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 Å resolution. Science (Wash. DC). 26:533-539.
20. Orlowski, M., C. Cardozo, and C. Michaud. 1993. Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry. 32:1563-1572.
21. Vimstsky, A., C. Michaud, J.C. Powers, and M. Orlowski. 1992. Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex. Biochemistry. 31: 9421-9428.
22. 2 protein domains. Immunogenetics. 31:169-178.
23. Demars, R., R. Rudersdorf, C. Chang, J. Petersen, J. Strandtmann, N. Korn, B. Sidwell, and H. Orr. 1985. Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens. Proc. Natl. Acad. Sci. USA. 82:8183-8187.
24. Parham, P., and F.M. Brodsky. 1981. Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum. Immunol. 3:277-299.
25. Yang, S.Y., N.H. Morshima, T. Alton, M.S. Pollack, E.J. Yunis, and B. Dupont. 1984. Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and -B allotypes. Immunogenetics. 19:217-231.
26. Davis, J.E., and P. Cresswell. 1990. Lack of detectable endocytosis of B lymphocyte MHC class II antigens using an antibody-independent technique. J. Immunol. 144:990-997.
27. 2-microglobulin. Immunogenetics. 25:228-233.
28. Salter, R.D., D.N. Howell, and P. Cresswell. 1986. Impaired assembly and transport of HLA-A and -B antigens in a mutant T × B cell hybrid. EMBO (Eur. Mol. Biol. Organ.) J. 5: 943-949.
29. Anderson, K.S., and P. Cresswell. 1994. A role for calnexin (IP90) in the assembly of class II MHC molecules. EMBO (Eur. Mol. Biol. Organ.) J. 13:675-682.
30. Jentsch, S. 1992. The ubiquitin-conjugation system. Annu. Rev. Genet. 26:179-207.
31. Hershko, A., and A. Ciechanover. 1992. The ubiquitin system for protein degradation. Annu. Rev. Biochem. 61:761-807.
32. Ellison, M.J., and M. Hochstrasser. 1991. Epitope-tagged ubiquitin. J. Biol. Chem. 266:21150-21157.
33. Goldberg, A.L., and K.L. Rock. 1992 Proteolysis, proteasomes and antigen presentation. Nature (Lond.). 357:375-379.
34. Roclse, J , M. Gromme, F. Momberg, G. Hammerling, and J. Neefjes. 1994. Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J. Exp. Med. 180:1591-1597.
35. Falk, K., O. Rotzschke, and H.G. Rammensee. 1990. Cellular peptide composition governed by major histocomparibility complex class I molecules. Nature (Lond.). 348:248-251.
36. Snyder, H.L., J.W. Yewdell, and J. Bennink. 1994. Trimming of antigenic peptides in an early secretory compartment. J. Exp. Med. 180:2389-2394.
37. Elliott, T., A. Willis, V. Cerundolo, and A. Townsend. 1995. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. J. Exp. Med. 181:1481-1491.
38. Fenteany, G., R.F. Standaert, W.S. Lane, S. Choi, E.J. Corey, and S.L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science (Wash. DC). 268:726-731.